Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DRD3 | P35462 | 20/20 | 0.57 |
| ▸ | DRD2 | P14416 | 15/20 | 0.57 |
| ▸ | DRD4 | P21917 | 7/20 | 0.57 |
| ▸ | HTR1A | P08908 | 5/20 | 0.51 |
| ▸ | HTR2A | P28223 | 3/20 | 0.51 |
| ▸ | HTR2C | P28335 | 3/20 | 0.51 |
| ▸ | DRD1 | P21728 | 2/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31348222 | 0.92 | DRD3 (0.58) | DRD3DRD2DRD4HTR1AHTR2A | |
| SCHEMBL31348151 | 0.91 | DRD3 (0.53) | DRD3DRD2DRD4HTR1AHTR2A | |
| SCHEMBL31348159 | 0.91 | DRD3 (0.53) | DRD3DRD2DRD4HTR1AHTR2A | |
| SCHEMBL31348183 | 0.90 | DRD3 (0.64) | DRD3DRD2DRD4HTR1AHTR2A | |
| SCHEMBL31348122 | 0.90 | DRD3 (0.47) | DRD3DRD2DRD4HTR1AHTR2A | |
| SCHEMBL31348162 | 0.87 | DRD3 (0.74) | DRD3DRD2DRD4HTR1AHTR2A | |
| SCHEMBL31348198 | 0.84 | DRD3 (0.46) | DRD3DRD2DRD4HTR1AHTR2A | |
| SCHEMBL31348173 | 0.80 | DRD3 (0.70) | DRD3DRD2DRD4HTR1AHTR2A | |
| SCHEMBL31348269 | 0.79 | DRD3 (0.58) | DRD3DRD2DRD4HTR1AHTR2A | |
| SCHEMBL31348181 | 0.78 | DRD3 (0.56) | DRD3DRD2DRD4HTR1AHTR2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025006982-A1 | POTENT AND SELECTIVE DOPAMINE D3 RECEPTOR ANTAGONISTS | THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 2025-01-02 | — | — | WO | disclosed |